We performed gene-targeting experiments by electroporating HiFi Cas9 and HBB-specific chemically modified guide sgRNAs46 into primary CD34+ HSPCs isolated from patients with sickle cell disease (which contained the E6V point mutation). Here, CD34 is linked to sickle cell disease.